BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SPECC1, FLJ36955, CYTSB, 92521, ENSG00000128487, Q5M775, NSP, HCMOGT-1 AND Treatment
9 results:

  • 1. Interference of the Circular RNA Sperm Antigen With Calponin Homology and Coiled-Coil Domains 1 Suppresses Growth and Promotes Apoptosis of breast cancer Cells Partially Through Targeting miR-1236-3p/Chromobox 8 Pathway.
    Zhang C; Wang J; Wang H; Li J
    Clin Breast Cancer; 2024 Apr; 24(3):e138-e151.e2. PubMed ID: 38341369
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
    Defossez G; Quillet A; Ingrand P
    BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy.
    Wedlake L; Shaw C; McNair H; Lalji A; Mohammed K; Klopper T; Allan L; Tait D; Hawkins M; Somaiah N; Lalondrelle S; Taylor A; VanAs N; Stewart A; Essapen S; Gage H; Whelan K; Andreyev HJN
    Am J Clin Nutr; 2017 Sep; 106(3):849-857. PubMed ID: 28679552
    [No Abstract]    [Full Text] [Related]  

  • 4. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
    Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
    Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype.
    Wang HJ; Guo YQ; Tan G; Dong L; Cheng L; Li KJ; Wang ZY; Luo HF
    J Cell Biochem; 2013 Oct; 114(10):2248-57. PubMed ID: 23606360
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Let-7: a regulator of the ERĪ± signaling pathway in human breast tumors and breast cancer stem cells.
    Sun X; Qin S; Fan C; Xu C; Du N; Ren H
    Oncol Rep; 2013 May; 29(5):2079-87. PubMed ID: 23467929
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Safety and cost-effectiveness of shortening hospital follow-up after breast cancer treatment.
    Lu W; Greuter MJ; Schaapveld M; Vermeulen KM; Wiggers T; de Bock GH
    Br J Surg; 2012 Sep; 99(9):1227-33. PubMed ID: 22828861
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.
    Sheihet L; Garbuzenko OB; Bushman J; Gounder MK; Minko T; Kohn J
    Eur J Pharm Sci; 2012 Feb; 45(3):320-9. PubMed ID: 22155544
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.
    Campora E; Giudici S; Merlini L; Rubagotti A; Rosso R
    Am J Clin Oncol; 1994 Dec; 17(6):522-6. PubMed ID: 7977174
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.